Healthcare - Biotechnology - NASDAQ - US
$ 33.215
0.651 %
$ 1.89 B
Market Cap
15.74
P/E
INCOME STATEMENT
582 M
REVENUE
192 M
OPERATING INCOME
129 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Harmony Biosciences Holdings, Inc.
| Revenue | 582 M |
| Cost Of Revenue | 121 M |
| Gross Profit | 461 M |
| Operating Expenses | 269 M |
| Operating Income | 192 M |
| Other Expenses | 63.2 M |
| Net Income | 129 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 582.0 | 437.9 | 305.4 | 159.7 | 6.0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 121.2 | 83.5 | 55.5 | 27.7 | 1.6 | 0.2 |
| Gross Profit | 460.8 | 354.4 | 249.9 | 132.0 | 4.4 | (0.2) |
| OPERATING INCOME | ||||||
| Operating Expenses | 268.8 | 234.2 | 162.4 | 115.0 | 150.3 | 41.4 |
| Selling, General and Administrative Expenses | 192.7 | 163.3 | 132.0 | 95.6 | 80.7 | 29.1 |
| Research and Development Expenses | 76.1 | 70.9 | 30.4 | 19.4 | 69.6 | 12.4 |
| Operating Income | 192.0 | 120.2 | 68.7 | 3.7 | (145.9) | (41.4) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 23.8 | 15.7 | 24.0 | 28.2 | 6.1 | 0 |
| Total Other Income | (18.6) | (15.5) | (50.1) | (53.9) | (6.1) | 1.5 |
| Pre-Tax Income | 173.4 | 104.7 | 37.4 | (36.9) | (152.0) | (39.9) |
| NET INCOME | ||||||
| Tax Provision | 44.5 | (76.8) | 2.8 | 14.9 | 6.1 | 1.5 |
| Net Income | 128.9 | 181.5 | 34.6 | (51.9) | (158.1) | (39.9) |
| EPS | 2.17 | 3.07 | 0.6 | 0.91 | 2.48 | 0.81 |